Profile
Gwynfor Owen Humphreys was the founder of Nektar Therapeutics UK Ltd.
which was founded in 1995, where he held the title of Managing Director from 1995 to 2001.
He also held former positions as Chief Executive Officer at Gunsynd Plc from 2004 to 2014, Non-Executive Director at Avacta Group Plc from 2010 to 2015, and Director at SolAeroMed, Inc.
Former positions of Gwynfor Owen Humphreys
| Companies | Position | End |
|---|---|---|
| AVACTA GROUP PLC | Chairman | 23/01/2014 |
| GUNSYND PLC | Chief Executive Officer | 14/09/2014 |
Nektar Therapeutics UK Ltd.
 Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Founder | 31/12/2000 |
SolAeroMed, Inc.
 SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Director/Board Member | - |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| GUNSYND PLC | Health Technology |
| AVACTA GROUP PLC | Commercial Services |
| Private companies | 2 |
|---|---|
Nektar Therapeutics UK Ltd.
Nektar Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Nektar Therapeutics, Nektar Therapeutics UK Ltd. develops and manages the exploitation of patented technology for controlled particle formation. The company is based in Bradford, UK. Nektar Therapeutics was acquired by Nektar Therapeutics on January 09, 2001 for $140.98 million. The British company was founded by Mazen Hanna, Gwynfor Owen Humphreys. | Health Technology |
SolAeroMed, Inc.
SolAeroMed, Inc. Pharmaceuticals: MajorHealth Technology SolAeroMed, Inc. develops biophysical respiratory drugs and delivery devices for asthma, cystic fibrosis, and chronic obstructive pulmonary disease (COPD). The company was founded by John Butt and Green Francis in 1995 and is headquartered in Calgary, Canada. | Health Technology |
- Stock Market
- Insiders
- Gwynfor Owen Humphreys
